gptkbp:instance_of
|
gptkb:Android
|
gptkbp:administered_by
|
injection
oral tablet
|
gptkbp:available_on
|
prescription medication
|
gptkbp:can_cause
|
gynecomastia in men
virilization in women
|
gptkbp:casnumber
|
10418-03-8
|
gptkbp:chemical_formula
|
C21 H32 N2 O
|
gptkbp:developed_by
|
gptkb:Winthrop_Laboratories
dihydrotestosterone
|
gptkbp:excretion
|
urine
|
https://www.w3.org/2000/01/rdf-schema#label
|
Stanozolol
|
gptkbp:introduced_in
|
gptkb:1962
|
gptkbp:is_associated_with
|
health risks
addiction potential
illegal use
|
gptkbp:is_available_in
|
various forms
|
gptkbp:is_banned_by
|
gptkb:World_Anti-Doping_Agency
|
gptkbp:is_considered
|
performance-enhancing drug
a controlled substance in many places
|
gptkbp:is_known_for
|
enhancing athletic performance
increasing muscle mass
improving endurance
improving strength
reducing body fat
|
gptkbp:is_metabolized_in
|
liver
|
gptkbp:is_part_of
|
steroid cycle
|
gptkbp:is_popular_in
|
gptkb:sports_championship
gptkb:Athletics
|
gptkbp:is_related_to
|
gptkb:anabolic_steroids
|
gptkbp:is_subject_to
|
gptkb:regulations
|
gptkbp:is_used_by
|
gptkb:athletes
gptkb:sports_championship
|
gptkbp:is_used_for
|
gptkb:hereditary_angioedema
gptkb:anemia
weight loss
muscle wasting
|
gptkbp:is_used_in
|
gptkb:animals
some medical treatments
|
gptkbp:legal_status
|
some countries
many sports organizations
|
gptkbp:side_effect
|
cardiovascular issues
liver damage
mood swings
hair loss
acne
|
gptkbp:suitable_for
|
gptkb:children
pregnant women
people with liver disease
people with heart problems
people with prostate cancer
|
gptkbp:bfsParent
|
gptkb:Ben_Johnson
|
gptkbp:bfsLayer
|
5
|